Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents.

× No keyword cloud information.

88 in total

1. Effects of oral and intravenous administration of buspirone on food-cocaine choice in socially housed male cynomolgus monkeys.

Authors: Paul W Czoty; Michael A Nader
Journal: Neuropsychopharmacology Date: 2015-03-13 Impact factor: 7.853

2. CJ-1639: A Potent and Highly Selective Dopamine D3 Receptor Full Agonist.

Authors: Jianyong Chen; Gregory T Collins; Beth Levant; James Woods; Jeffrey R Deschamps; Shaomeng Wang
Journal: ACS Med Chem Lett Date: 2011-08-11 Impact factor: 4.345

3. Selectivity and activation of dopamine D3R from molecular dynamics.

Authors: Zhiwei Feng; Tingjun Hou; Youyong Li
Journal: J Mol Model Date: 2012-07-03 Impact factor: 1.810

Review 4. Bacterial cocaine esterase: a protein-based therapy for cocaine overdose and addiction.

Authors: Diwahar Narasimhan; James H Woods; Roger K Sunahara
Journal: Future Med Chem Date: 2012-02 Impact factor: 3.808

5. Eating high-fat chow increases the sensitivity of rats to quinpirole-induced discriminative stimulus effects and yawning.

Authors: Michelle G Baladi; Charles P France
Journal: Behav Pharmacol Date: 2010-10 Impact factor: 2.293

6. Dopamine D(3) receptors contribute to methamphetamine-induced alterations in dopaminergic neuronal function: role of hyperthermia.

Authors: Michelle G Baladi; Amy H Newman; Shannon M Nielsen; Glen R Hanson; Annette E Fleckenstein
Journal: Eur J Pharmacol Date: 2014-03-28 Impact factor: 4.432

Review 7. Neural circuitry and mechanisms of waiting impulsivity: relevance to addiction.

Authors: Jeffrey W Dalley; Karen D Ersche
Journal: Philos Trans R Soc Lond B Biol Sci Date: 2019-02-18 Impact factor: 6.237

8. The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions.

Authors: Arlene C Pak; Charles R Ashby; Christian A Heidbreder; Maria Pilla; Jeremy Gilbert; Zheng-Xiong Xi; Eliot L Gardner
Journal: Int J Neuropsychopharmacol Date: 2006-08-31 Impact factor: 5.176

9. Discriminative stimulus properties of S32504, a novel D3/D2 receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D2 but not D3 receptors.

Authors: Mark J Millan; Loretta Iob; Jean-Louis Péglion; Anne Dekeyne
Journal: Psychopharmacology (Berl) Date: 2006-09-19 Impact factor: 4.530

10. Analogues of the dopamine D2 receptor antagonist L741,626: Binding, function, and SAR.

Authors: Peter Grundt; Sarah Little Jane Husband; Robert R Luedtke; Michelle Taylor; Amy Hauck Newman
Journal: Bioorg Med Chem Lett Date: 2006-10-28 Impact factor: 2.823